Exor N.V. Has $608.65 Million Stock Position in Clarivate Plc (NYSE:CLVT)

Exor N.V. boosted its position in shares of Clarivate Plc (NYSE:CLVTFree Report) by 102.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 65,728,365 shares of the company’s stock after acquiring an additional 33,256,346 shares during the period. Clarivate makes up about 15.8% of Exor N.V.’s investment portfolio, making the stock its 2nd largest position. Exor N.V. owned about 0.10% of Clarivate worth $608,645,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Banque Cantonale Vaudoise acquired a new stake in Clarivate in the 3rd quarter valued at about $33,000. Montag A & Associates Inc. lifted its position in Clarivate by 729.6% during the fourth quarter. Montag A & Associates Inc. now owns 7,732 shares of the company’s stock worth $72,000 after acquiring an additional 6,800 shares during the last quarter. Forum Financial Management LP acquired a new stake in Clarivate during the third quarter worth approximately $81,000. Wedmont Private Capital acquired a new stake in Clarivate during the fourth quarter worth approximately $99,000. Finally, Simplicity Solutions LLC acquired a new stake in Clarivate during the third quarter worth approximately $108,000. 85.72% of the stock is currently owned by institutional investors and hedge funds.

Clarivate Stock Down 0.1 %

Shares of NYSE:CLVT traded down $0.01 during midday trading on Thursday, hitting $6.94. 3,737,652 shares of the company’s stock were exchanged, compared to its average volume of 4,066,111. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.91 and a quick ratio of 0.91. The stock has a 50 day moving average price of $7.29 and a 200-day moving average price of $7.87. The company has a market cap of $4.63 billion, a PE ratio of -4.70, a price-to-earnings-growth ratio of 1.39 and a beta of 1.24. Clarivate Plc has a 12 month low of $6.07 and a 12 month high of $10.03.

Clarivate (NYSE:CLVTGet Free Report) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.21 earnings per share for the quarter, hitting the consensus estimate of $0.21. Clarivate had a negative net margin of 34.66% and a positive return on equity of 9.95%. The business had revenue of $683.70 million for the quarter, compared to analysts’ expectations of $687.80 million. During the same period in the previous year, the company earned $0.20 earnings per share. The firm’s revenue for the quarter was up 1.2% compared to the same quarter last year. On average, sell-side analysts anticipate that Clarivate Plc will post 0.62 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

CLVT has been the topic of several recent research reports. Royal Bank of Canada lowered their target price on shares of Clarivate from $10.00 to $8.00 and set a “sector perform” rating on the stock in a report on Wednesday, February 28th. Oppenheimer cut their target price on shares of Clarivate from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 28th. Barclays cut their target price on shares of Clarivate from $7.00 to $6.00 and set an “underweight” rating on the stock in a research report on Wednesday, February 28th. Finally, Morgan Stanley cut their target price on shares of Clarivate from $9.00 to $8.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 28th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $8.00.

View Our Latest Research Report on CLVT

About Clarivate

(Free Report)

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.

Further Reading

Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate Plc (NYSE:CLVTFree Report).

Institutional Ownership by Quarter for Clarivate (NYSE:CLVT)

Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.